Executives Cash Out While One CEO Buys Dip

Fresh filings this week reveal a sharp split in executive sentiment. Most C-suite insiders are selling. One stands out by going the other way.

BSX CEO Michael Mahoney filed on August 5th that he bought $9M worth of Boston Scientific shares. The purchase covered 186,240 shares at around $48. That's a rare vote of confidence from a sitting chief executive.

Meanwhile, sellers are piling up. Charles Schwab's founder filed four separate sales totalling over $30M in SCHW shares across late July and early August. The trades were made between $105 and $106 per share.

LTH Chairman and CEO Bahram Akradi filed an exit worth nearly $19.5M. Three Life Time Group insiders collectively sold $24.5M of stock this week — the largest cluster of insider selling in US markets over the period.

PBF Energy saw two insiders file sales totalling $36.6M. That's the biggest multi-insider sell-off in the dataset.

CAKE founder David Overton filed a $10M sale. Two Cheesecake Factory insiders sold a combined $10.8M this week.

On the buy side, PFE saw two insiders file purchases worth nearly $2M combined — a small but notable sign of internal confidence at Pfizer.

This article is not financial advice.